Work

Modern Possibilities of Hormone Targeted Therapy in Metastatic Receptor-Positive HER2-Negative Breast Сancer. A Clinical Case

Year: 2024

Type: article

Abstract: The article considers a clinical case that clearly demonstrates the positive effect of a combination of targeted therapy, including CDK4/6i (ribociclib), and an aromatase inhibitor in the first line of therapy in a premenopausal patient with hormonal receptor-positive HER2-negative (HR+/HER2-) metastatic breast cancer.

Source: Effective Pharmacotherapy

DOI: 10.33978/2307-3586-2024-20-22-14-16

Authors: A.S. Shatokhina, M.G. Leonov, Yu.A. Shevchenko, S.A. Belyaeva, Novorossiysk Oncological Dispensary No. 3

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4402861694

FWCI:

Cites:

Cited by:

Related to: 10